Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Director's Dealing 2013

Sep 13, 2013

34023_dirs_2013-09-13_8365910a-68ba-449a-98b7-48c719212008.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2013-09-12

Reporting Person: Wentworth Kerry (VP, Clinical, Reg, & Quality)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-09-12 Stock Option, Right to Buy $2.72 A 40000 Acquired 2016-09-12 Common Stock (40000) Direct

Footnotes

F1: Options awarded in accordance with the Agenus Inc. 2009 Equity Incentive Plan and vest based on the achievement of performance milestones as determined by the Compensation Committee of the Board of Directors of Agenus Inc.